TRADING DAY Making sense of the forces driving global markets By Jamie McGeever, Markets Columnist Deep uncertainty, thin ...

Using CytomX’s Probody and Regeneron’s Veloci-Bi platforms, the collaboration and licensing agreement aims to enable the development of investigational next-generation bispecific immunotherapies.

Earlier in 2019 Sanofi also paid Regeneron $462 million to exit from an immuno-oncology alliance formed in 2015, and in 2017 said they would end discovery research in new antibody drugs.

Future Pro Football Hall of Fame quarterback Tom Brady knows what it's like to wait your turn in the NFL Draft, and he sent some encouragement Shedeur Sanders' way after his 2025 NFL Draft slide.

Legendary investor Warren Buffett and his Berkshire Hathaway conglomerate suffered a rare setback Monday following the 94-year-old’s announcement he would step aside as Berkshire’s CEO at the ...

Each year, we publish a special issue featuring the 500 most influential people in Washington. With a new administration now in place, these power players’ expertise and strategic insight are ...

Celsius posted Q1 revenue of $329.3M, down 7% YoY and below the $344M estimate, citing timing of incentives and promotions. Adjusted EBITDA fell 21% to $69.7M; net income dropped 43% despite gross ...

After a few weeks smoldering in the background, investors' worries over trade, tariffs and growth are very much back on the front burner. Figures on Tuesday showed the U.S. trade deficit swelled ...

Britain and India clinch major trade deal in ’new era’of Trump tariffs After a few weeks smoldering in the background, investors’ worries over trade, tariffs and growth are very much back on ...